A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma
Pfizer
Pfizer
Alpha Tau Medical LTD.
Pfizer
Regeneron Pharmaceuticals
Novartis
DEKA Biosciences
Regeneron Pharmaceuticals
Tempus AI
Barco NV
Checkpoint Therapeutics, Inc.